The latest Investing Matters Podcast episode with Inclusive Asset Management's Alexandra McGuigan has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScancell Holdings Share News (SCLP)

Share Price Information for Scancell Holdings (SCLP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.65
Bid: 9.50
Ask: 9.80
Change: -0.20 (-2.03%)
Spread: 0.30 (3.158%)
Open: 9.75
High: 9.85
Low: 9.65
Prev. Close: 9.85
SCLP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Metro Bank Slumps 29% On Annual Profit Miss

Wed, 23rd Jan 2019 10:41

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - WINNERS----------easyJet, up 1.9%. The airline was extending Tuesday's gains after backing its annual guidance and posting a 14% rise in first quarter revenue to GBP1.30 billion.----------FTSE 100 - LOSERS----------Ferguson, down 2.2%. Exane BNP cut its rating on the plumbing firm to Underperform from Neutral.----------Burberry, down 0.9%. The fashion house reported a slight dip in its third quarter retail revenue, as it prepares to launch its new collection under the direction of recently installed Chief Creative Officer Riccardo Tisci next month. For the three months to the end of December, including the key Black Friday and Christmas periods, the upmarket fashion retailer suffered a 1.0% decline in total retail revenue to GBP711 million from GBP719 million a year ago. Comparable sales stores were up 1% in the period with "consistent performance across regions", the retailer added. Asia Pacific sales were aided by a good performance in China, which reported sales growth by mid-single digits.----------FTSE 250 - WINNERS----------RPC Group, up 4.6% at 767.40 pence. The plastic products maker was higher after agreeing to be taken over in a deal worth GBP3.3 billion. Under the terms of the agreement, RPC shareholders will receive 782.00 pence in cash per share from Apollo Management IX. They also will be entitled to the previously declared 8.1p dividend to be paid on Friday. The offer price, together with the dividend, represents a 16% premium to RPC's closing price on September 7, the date before the first approach fro the company's takeover was made. The deadline for the takeover offer, which was lastly set for Wednesday, has been extended five times before the proposal was agreed by the two companies. RPC directors unanimously recommended shareholders to accept the terms of the offer which they consider to be "fair and reasonable". ----------Computacenter, up 4.1%. The IT infrastructure services provider said it "materially performed" its annual expectations, achieving "record revenue and profitability". For 2018, the company expects revenue to rise 8% on the prior year, excluding acquisitions made during the year. At constant currency revenue is expected to rise 7%. Pretax profit for the recently ended financial year is seen "marginally ahead" of the company's expectations. For 2017, the FTSE 250-listed firm posted revenue of GBP3.79 billion and pretax profit of GBP111.7 million. Looking ahead at 2019, Computacenter said it expects further financial progress driven by "customers' appetite to invest in digital technology to enhance their business". ----------FTSE 250 - LOSERS----------Metro Bank, down 29%. The challenger bank said trading in the fourth quarter followed the trends it experienced in the firth three quarters, with loans and deposits seeing a sharp rise. However, its underlying pretax profit for 2018 of GBP50 million, though more than double the GBP21 million achieved last year, came in below consensus forecasts of GBP59 million. Metro ended 2018 with loans of GBP14.2 billion compared to GBP9.6 billion at the end of 2017, a 48% increase. The bank's customer loans increased GBP1.1 billion in the fourth quarter. The challenger bank's deposits increased 34% in 2018 to GBP15.7 billion from GBP11.7 billion. Metro Bank's deposit growth per store per month however slowed to GBP5.9 million from GBP6.3 million.----------Sanne Group, down 13%. The alternative asset and corporate services provider said Chief Executive Dean Godwin has decided to retire from the firm after seven years at its head. Martin Schnaier, previously chief commercial officer, will succeed Godwin as CEO in May. Updating on trading, Sanne said it achieved "record new business with sales wins representing GBP13.0 million of additional annualised revenue". The company expects to report underlying profit before tax for the year to 2018 broadly in line with its expectations. So far in 2019, Sanne is pleased with initial performance and it remains confident in the group's prospects. ----------G4S, down 4.5%. The security services provider has agreed to settle a class action against the firm in California. The action, covering around 13,500 employees' meal and rest breaks between 2001 and 2010, is the third such G4S has faced in recent years in California. It will pay between USD100 million and USD130 million, with a precise amount to be finalised during the settlement administration process. "The company estimates that financial settlement will occur in the second half of 2019. The appropriate provision for the cost of the settlement will be recognised as a specific item in the 2018 full year results," G4S said in a statement.----------OTHER MAIN MARKET AND AIM - WINNERS----------EVR Holdings, up 13%. The virtual reality content creator said its subsidiary MelodyVR has signed an addendum to its distribution agreement with Oculus VR, a part of Facebook Technologies. EVR will release a new version of the MelodyVR music platform, with updated features and functionality, for use on a forthcoming Oculus device. Following the launch, the product may also be made available on other platforms. EVR Holdings said it will receive a financial contribution to offset MelodyVR's production and development costs as part of the agreement. ----------Clearstar, up 11%. The background screening software company said it expects to report its highest ever annual revenue in 2018, while also announcing its chief financial officer has decided to step down. The company's financial controller, Jennifer Balleza, has been appointed interim CFO. The firm expects revenue of USD20.1 million for 2018, a 13% increase on the USD17.8 million recorded the year before. ClearStar said its revenue in the second half was 15% higher than the USD9.9 million revenue reported in the first half. ClearStar recorded an adjusted Ebitda loss in 2017, which it now expects to swing to a profit.----------OTHER MAIN MARKET AND AIM - LOSERS----------Scancell Holdings, down 15%. The company, which develops immunotherapies for the treatment of cancer, said its Project Blueprint proposal was not selected for the Cancer Research UK Grand Challenge grant. Scancell's Project Blueprint - which was submitted with BioNTech, Genentech and ISA Pharmaceuticals - wanted to investigate the potential of cancer vaccines based on treatment with Modi-3, a Scancell product developed from its Moditope platform. The proposal would also look into vaccines targeting "new mutations within individual patient tumours, for the treatment of virtually all cancers". ----------

More News
26 Mar 2024 14:00

Scancell doses first patient in melanoma-focused trials

(Alliance News) - Scancell Holdings PLC announced on Tuesday that the first patient of a new trial cohort has been dosed with its iSCIB1+ therapeutic.

Read more
5 Feb 2024 14:09

TRADING UPDATES: Alliance Pharma appoints chair; FireAngel sales down

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
30 Jan 2024 13:56

Scancell interim loss narrows amid finance gain on derivative

(Alliance News) - Scancell Holdings PLC on Tuesday reported a narrowed loss as it gained on the revaluation of derivative liability.

Read more
17 Jan 2024 14:26

IN BRIEF: Scancell approved by MHRA to add new cohort to Scope trial

Scancell Holdings PLC - Oxford, England-based developer of immunotherapies for treatment of cancer and infectious disease said - Receives approval from UK's Medicines & Healthcare products Regulatory agency to add a third cohort to the Scope trial. Says the cohort will consist of 43 melanoma patients who will receive iSCIB1+ with doublet therapy, consisting of ipilimumab, under the brand name Yervoy, plus nivolumab, under the name Opdivo. "Exceptional" results from the first 13 patients receiving SCIB1 in the ongoing Scope trial, with an objective response rate of 85%, indicate a high probability of success in this cohort, which is expected to complete in the second quarter of 2024. Meanwhile, recruitment into the iSCIB1+ cohort is expected to be complete by the end of the second quarter as well, with early data expected in the third quarter of 2024.

Read more
19 Dec 2023 13:35

Scancell raises GBP12 million in total from fundraise

(Alliance News) - Scancell Holdings PLC on Tuesday said it has raised GBP11.9 million in total, from an open offer, placing, and subscription of shares.

Read more
1 Dec 2023 09:54

IN BRIEF: Scancell raises GBP10.7 million in upsized share sale

Scancell Holdings PLC - Oxford, England-based developer of immunotherapies for treatment of cancer and infectious disease - Raises GBP10.7 million from the placing and subscription of 97.0 million new shares at 11 pence each. The placing is run by Stifel Nicolaus Europe Ltd and WG Partners LLP. Scancell also plans an open offer of shares at the same price to raise up to another GBP2.0 million. Scancell says the placing was oversubscribed and upsized as a result. After the London market close on Thursday, Scancell had announced plans to raise just GBP6 million in the placing. It says the raise was led by "new institutional and life science specialist investors".

Read more
30 Nov 2023 21:10

EARNINGS AND TRADING: Dispensa and SkinBioTherapeutics losses widen

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
28 Nov 2023 14:57

TRADING UPDATES: Scancell trial progresses; OptiBiotix inks new deal

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
22 Nov 2023 15:53

UK shareholder meetings calendar - next 7 days

Thursday 23 November 
abrdn UK Smaller Companies Growth Trust PLCAGM
Avation PLCAGM
Bradda Head Lithium LtdAGM
DX Group PLCAGM
Europa Oil & Gas Holdings PLCAGM
Fiske PLCAGM
JPMorgan UK Smaller Cos Investment Trust PLCAGM
Hotel Chocolat Group PLCAGM
Pacific Horizon Investment Trust PLCAGM
Pan African Resources PLCAGM
PZ Cussons PLCAGM
Rosslyn Data Technologies PLCAGM
Friday 24 November 
Base Resources LtdAGM
Cloudbreak Discovery PLCAGM
Esken LtdEGM re Esken Renewables disposal
Neometals LtdAGM
Sovereign Metals LtdAGM
Sylvania Platinum LtdAGM
Monday 27 November 
Chelverton Growth Trust PLCGM re voluntary liquidation
European Smaller Cos Trust PLCAGM
JPMorgan Global Emerging Markets Income Trust PLCAGM
Quadrise PLCAGM
Tribal Group PLCGM re cash offer by Tiger Bidco 1 Ltd
Tuesday 28 November 
Bluefield Solar Income Fund LtdAGM
London Finance & Investment Group PLCAGM
Nanoco Group PLCAGM
Oakley Capital Investments LtdAGM
Wednesday 29 November 
Artemis Resources LtdAGM
Aura Energy LtdAGM
Contango Holdings PLCAGM
CVS Group PLCAGM
Fidelity Asian Values PLCAGM
Ikigai Ventures LtdAGM
Panthera Resources PLCAGM
Reconstruction Capital II LtdAGM
Renishaw PLCAGM
RiverFort Global Opportunities PLCAGM
Sabien Technology Group PLCAGM
Scancell Holdings PLCAGM
Seeing Machines LtdAGM
SLF Realisation Fund LtdAGM
Target Healthcare REIT PLCAGM
Thor Energy PLCAGM
Transense Technologies PLCAGM
Vast Resources PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
10 Nov 2023 11:14

IN BRIEF: Scancell shares up as presents "trailblazing" trial data

Scancell Holdings PLC - Nottingham, England-based cancer immunotherapies developer - Presents data from first stage of Phase 2 Scope trial at 20th International Congress of the Society for Melanoma Research on Thursday. Trial investigates Scancell's SCIB1 vaccination combined with checkpoint inhibitors in advanced melanoma. Company reported mid-September that SCIB1 combined with CPIs showed an 82% objective response rate. Scope trial is currently in its second stage. Scancell says on Friday that in Cohort 1 nine responses were achieved earlier than expected, and probability of second-stage success is around 90% based on current data.

Read more
31 Oct 2023 14:45

EARNINGS: Frontier IP chair to step down; "busy" Rosslyn narrows loss

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
20 Oct 2023 09:00

IN BRIEF: Scancell says needs more time to publish annual results

Scancell Holdings PLC - Nottingham, England-based cancer immunotherapies developer - Says auditor request additional time to complete standard audit of its results of financial year 2023 that ended on April 30. Cites unforeseen circumstances impacting the audit engagement team. Says audit is substantially complete without any material audit issues.

Read more
17 Oct 2023 15:43

UK earnings, trading statements calendar - next 7 days

Wednesday 18 October 
888 Holdings PLCTrading Statement
Antofagasta PLCTrading Statement
BHP Group LtdTrading Statement
Cirata PLCTrading Statement
Hochschild Mining PLCTrading Statement
Liontrust Asset Management PLCTrading Statement
Quilter PLCTrading Statement
Segro PLCTrading Statement
Sosandar PLCTrading Statement
Whitbread PLCHalf Year Results
Thursday 19 October 
AJ Bell PLCTrading Statement
Centamin PLCQ3 Results
Deliveroo PLCTrading Statement
Dunelm Group PLCTrading Statement
GB Group PLCTrading Statement
Gear4Music PLCHalf Year Results
Hargreaves Lansdown PLCTrading Statement
London Stock Exchange Group PLCTrading Statement
Man Group PLCTrading Statement
Mondi PLCTrading Statement
PensionBee Group PLCTrading Statement
Rathbones Group PLCTrading Statement
Relx PLCTrading Statement
Rentokil Initial PLCQ3 Results
Sabre Insurance Group PLCTrading Statement
Schroders PLCTrading Statement
St James's Place PLCTrading Statement
Friday 20 October 
Foxtons Group PLCTrading Statement
InterContinental Hotels Group PLCTrading Statement
Record PLCTrading Statement
Monday 23 October 
Shanta Gold LtdTrading Statement
South32 LtdTrading Statement
Tuesday 24 October 
Angling Direct PLCHalf Year Results
Anglo American PLCTrading Statement
Barclays PLCQ3 Results
Bunzl PLCTrading Statement
FD Technologies PLCHalf Year Results
Gattaca PLCFull Year Results
Petra Diamonds LtdQ1 Results
Scancell Holdings PLCFull Year Results
Softcat PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
WAG Payment Solutions PLCTrading Statement
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
22 Sep 2023 13:05

IN BRIEF: Oxford Technology 2 VCT asset value hurt by AIM share falls

Oxford Technology 2 VCT PLC - venture capital trust investing in quoted and unquoted technology companies - Net asset value of OT1 shares falls by 16% to 37.9 pence on August 31 from 45.3p on February 28. Similarly, NAV of OT2 shares falls to 20.5p from 25.1p, of OT3 shares to 23.6p from 33.7p, and of OT4 shares to 25.4p from 29.7p. No dividends are paid during the half year, nor are any shares bought back.

Read more
19 Sep 2023 14:32

Scancell celebrates "positive" clinical trial data for cancer vaccine

(Alliance News) - Scancell Holdings PLC shares surged on Tuesday after the company announced positive results from the phase 2 clinical trial of its SCIB1 treatment for advanced melanoma.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.